We first identified the expression level of CCL2, FOS, JUN in IgAN, lupus nephritis, diabetic nephropathy, focal segmental glomerulosclerosis, minimal change disease, and membranous glomerulonephropathy, respectively. This evidence concerns the gene JUN and focal segmental glomerulosclerosis.